Postbiotic delivery via alginate encapsulation alleviates DSS-induced colitis by modulating gut microbiota and SCFA-mediated immune signaling.

Probiotic therapies for IBD are limited by low gastrointestinal viability and inconsistent efficacy. Postbiotics, non-viable microbes or their metabolites, offer a safer, more stable option, yet their distinct functions remain unclear, largely due to…

Preview only. Read the full abstract at the source